CClinicalTrials.gg
CompletedNCT01316367Updated Mar 16, 2011

Effectiveness of PRECEDE Model for Health Education on Changes and Level of Control in Patients With Type 2 Diabetes Mellitus

A Phase 4 interventional study of PRECEDE HPE model and CHPE in Type 2 Diabetes Mellitus and Cardiovascular Risk Factor, sponsored by Hospital Carlos III, Madrid. Completed at 1 site in Spain. Open to participants aged 31 Years and older. Per ClinicalTrials.gov, last updated 2011-03-16.

Sponsored by Hospital Carlos III, Madrid · Phase 4, Interventional, and Prevention

Phase
Phase 4
Study type
Interventional
Enrollment
600
Allocation
Randomized
Ages
31 Years and older
Sex
All
01

Study summary

BACKGROUND: Individual health education is considered to be essential in the overall care of patients with type 2 diabetes (DM2), although there is some uncertainty regarding its metabolic control benefits. There have been very few randomized studies on the effects of individual education on normal care in DM2 patients with a control group, and none of these have assessed the long-term results. Therefore, this study aims to use this design to assess the effectiveness of the PRECEDE (Predisposing, Reinforcing, Enabling, Causes in Educational Diagnosis, and Evaluation) education model in the metabolic control and the reduction of cardiovascular risk factors, in patients with type 2 diabetes.

METHODS: An open community randomized clinical trial will be carried out in 8 urban community health centers in the Northeastern Madrid (Spain). Six hundred patients with DM2 will be randomized in two groups: PRECEDE or conventional model for health promotion education. The main outcome measures is glycated hemoglobin A1C, body mass index (BMI), blood pressure, lipids and control criteria during the 2-year follow-up period.

Read the detailed description

Assignment to the Health Promotion Education (HPE) will be random, three centers will use conventional HPE (the control group) and the remaining five will use PRECEDE-type HPE. Eligible patients are selected from a list of DM2 patients by each professional using random sampling, until the predetermined sample size is attained.

Conventional HPE is defined according to the recommendations of the Spanish Ministry of Health National Conference on Diabetes Mellitus, and was complemented by the criteria for good care of the Madrid Primary Healthcare Service for the promotion of healthy lifestyles among adults for 2004-2007

02

Conditions studied

  • Type 2 Diabetes Mellitus
  • Cardiovascular Risk Factor

Keywords

  • Health Promotion Education
  • Type 2 Diabetes Mellitus
  • Cardiovascular Risk Factors
  • Spain
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 600 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Hospital Carlos III, Madrid is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
31 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Older than 30 years of age, with previously diagnosed DM2 (cardinal clinical, plus random blood glucose > 200 mg/dl or oral glucose of > 200 mg/dl at 2 h, twice, or plasma fasting glucose of > 126 mg/dl on two occasions or being diagnosed previously, received specific treatment for DM2)

Exclusion criteria

Exclusion Criteria:

  • Gestational diabetes
  • Patients involved in clinical trials
  • Patients with life expectancy less than 1 year (according to clinical judgment)
  • Patients who refused to participate
  • Homebound patients Patients meeting criteria for inclusion and not meeting any exclusion criteria were invited to participate, and were included after accepting and signing an informed consent form.
05

Study design

Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
600 participants (actual)

Study arms

  • Active comparator
    Conventional Health Promotion Education (CHPE).

    The CHPE model was defined according to the recommendations of the Spanish Ministry of Health National Conference on Diabetes Mellitus, which was complemented by criteria for good care of the Madrid Primary Healthcare Service for the promotion of healthy lifestyles among adults (2004-2007). The model is based on the following aspects: self-monitoring of glycaemic control, physical exercise, diet, weight management, and times of the day when the patient was most vulnerable to overeating, and given improved understanding of the relative effects of certain food choices on blood glucose control, medication adherence and smoking cessation.

    Behavioral: CHPE

  • Experimental
    PRECEDE HPE model

    Behavioral: PRECEDE HPE model

Interventions

  • BehavioralPRECEDE HPE model

    The model considers the influence of the following three factors on health-related behavior: * Predisposing: factors influencing the patient's motivation to undertake the behavior to be analyzed or encouraged. * Facilitators: factors influencing the level of easiness or difficulty the patient and his/her family have in undertaking a given behavior. * Reinforcing: factors arising after the patient has undertaken the behavior, and which reward or punish it.

  • BehavioralCHPE

    The CHPE model was defined according to the recommendations of the Spanish Ministry of Health National Conference on Diabetes Mellitus, which was complemented by criteria for good care of the Madrid Primary Healthcare Service for the promotion of healthy lifestyles among adults (2004-2007). The model is based on the following aspects: self-monitoring of glycaemic control, physical exercise, diet, weight management, and times of the day when the patient was most vulnerable to overeating, and given improved understanding of the relative effects of certain food choices on blood glucose control, medication adherence and smoking cessation.

06

What researchers measure

Primary outcomes

  1. HbA1c level

    Time frame: Final (before 2 years follow-up)

Secondary outcomes

  1. Blood Pressure

    Systolic and Diastolic Blood Pressure

    Time frame: Final (before 2 years follow-up)

  2. Low-density lipoprotein (LDL) cholesterol

    Time frame: Final (before 2 years of follow-up)

  3. Body Mass Index (BMI)

    Time frame: Final (before 2 years of follow-up

07

Study locations

1 site
  • Hospital Carlos III, Madrid
    Madrid, 28029, Spain
08

References and documents

Publications

  • Salinero-Fort MA, Carrillo-de Santa Pau E, Arrieta-Blanco FJ, Abanades-Herranz JC, Martin-Madrazo C, Rodes-Soldevila B, de Burgos-Lunar C. Effectiveness of PRECEDE model for health education on changes and level of control of HbA1c, blood pressure, lipids, and body mass index in patients with type 2 diabetes mellitus. BMC Public Health. 2011 Apr 28;11:267. doi: 10.1186/1471-2458-11-267. PubMed 21524316 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 16, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01316367
Lead sponsor
Hospital Carlos III, Madrid
First posted
Mar 16, 2011
Start date
Feb 2003
Primary completion
Feb 2005
Completion
Mar 2005
Last update
Mar 16, 2011

Study contacts

Miguel A Salinero, MD
principal investigator · Hospital Carlos III, Madrid

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2003. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion